Promotion of osteogenesis through β-catenin signaling by desferrioxamine

Biochemical and Biophysical Research Communications

Volumn 370, Issue 2, 2008, Pages 332-337

  Qu, Zhi Hu ^a   Zhang, Xiao Ling ^a   Tang, Ting Ting ^b   Dai, Ke Rong ^a,b  

^a SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

catenin; BMP2; Desferrioxamine; GSK 3 ; Osteogenesis; Wnt

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; DEFEROXAMINE; GLYCOGEN SYNTHASE KINASE 3BETA;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ALKALINE PHOSPHATASE; ANIMALS; BETA CATENIN; BONE MORPHOGENETIC PROTEINS; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; DEFEROXAMINE; HUMANS; MESENCHYMAL STEM CELLS; MICE; OSTEOBLASTS; OSTEOGENESIS; PLURIPOTENT STEM CELLS; RNA INTERFERENCE; SIDEROPHORES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

MURINAE;

EID: 42449094897     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.092     Document Type: Article

References (21)

1. Zhou S., Lechpammer S., Greenberger J.S., and Glowacki J. Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factor-beta/Smad3 signaling. J. Biol. Chem. 280 (2005) 22688-22696
2. Hirsila M., Koivunen P., Xu L., Seeley T., Kivirikko K.I., and Myllyharju J. Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J. 19 (2005) 1308-1310
3. Vengellur A., Woods B.G., Ryan H.E., Johnson R.S., and LaPres J.J. Gene expression profiling of the hypoxia signaling pathway in hypoxia-inducible factor 1alpha null mouse embryonic fibroblasts. Gene Expr. 11 (2003) 181-197
4. Gonzalez Suarez I., Fernandez Martin J.L., Naves Diaz M., and Cannata Andia J.B. [Effect of desferrioxamine and deferiprone on osteocalcin secretion in osteoblast-type cells]. Nefrologia 23 Suppl 2 (2003) 27-31
5. Naves Diaz M.L., Elorriaga R., Canteros A., and Cannata Andia J.B. Effect of desferrioxamine and deferiprone (L1) on the proliferation of MG-63 bone cells and on phosphatase alkaline activity. Nephrol. Dial. Transplant. 13 Suppl 3 (1998) 23-28
6. Behrens J., von Kries J.P., Kuhl M., Bruhn L., Wedlich D., Grosschedl R., and Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382 (1996) 638-642
7. Wu G., and He X. Threonine 41 in beta-catenin serves as a key phosphorylation relay residue in beta-catenin degradation. Biochemistry 45 (2006) 5319-5323
8. Bain G., Muller T., Wang X., and Papkoff J. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem. Biophys. Res. Commun. 301 (2003) 84-91
9. Jackson A., Vayssiere B., Garcia T., Newell W., Baron R., Roman-Roman S., and Rawadi G. Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. Bone 36 (2005) 585-598
10. Sun H., Wu C., Dai K., Chang J., and Tang T. Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite-bioactive ceramics. Biomaterials 27 (2006) 5651-5657
11. Lou J., Xu F., Merkel K., and Manske P. Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J. Orthop. Res. 17 (1999) 43-50
12. Wang E.A., Israel D.I., Kelly S., and Luxenberg D.P. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9 (1993) 57-71
13. Ju W., Hoffmann A., Verschueren K., Tylzanowski P., Kaps C., Gross G., and Huylebroeck D. The bone morphogenetic protein 2 signaling mediator Smad1 participates predominantly in osteogenic and not in chondrogenic differentiation in mesenchymal progenitors C3H10T1/2. J. Bone Miner. Res. 15 (2000) 1889-1899
14. Yun K., and Im S.H. Transcriptional regulation of MMP13 by Lef1 in chondrocytes. Biochem. Biophys. Res. Commun. 364 (2007) 1009-1014
15. van de Wetering M., Oving I., Muncan V., Pon Fong M.T., Brantjes H., van Leenen D., Holstege F.C., Brummelkamp T.R., Agami R., and Clevers H. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4 (2003) 609-615
16. Kim Y.K., Lee S.K., Ha M.S., Woo J.S., and Jung J.S. Differential role of reactive oxygen species in chemical hypoxia-induced cell injury in opossum kidney cells and rabbit renal cortical slices. Exp. Nephrol. 10 (2002) 275-284
17. Zhong N., Gersch R.P., and Hadjiargyrou M. Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation. Bone 39 (2006) 5-16
18. Hagen T., and Vidal-Puig A. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45. Biochem. Biophys. Res. Commun. 294 (2002) 324-328
19. Asahina I., Sampath T.K., and Hauschka P.V. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp. Cell Res. 222 (1996) 38-47
20. Katagiri T., Yamaguchi A., Ikeda T., Yoshiki S., Wozney J.M., Rosen V., Wang E.A., Tanaka H., Omura S., and Suda T. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem. Biophys. Res. Commun. 172 (1990) 295-299
21. Rawadi G., Vayssiere B., Dunn F., Baron R., and Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J. Bone Miner. Res. 18 (2003) 1842-1853